Health of Vegetarians and Vegans: Findings From EPIC-Oxford and Othe…

Physicians Committee for Responsible Medicine

T. J. Key

Is Obesity Management the Next Frontier?

Canadian Collaborative Research Network

A. Michael Lincoff

SGLT2 Inhibitors and Heart Failure in Type-2 Diabetes Mellitus

Javed Butler

Highlights From the 81st ADA Scientific Sessions: The AMPLITUDE Study

Richard Pratley

Pre-Operative Medical Evaluation Update

Scripps Health

J. Diamant

ADA 2022: Heart Failure Hospitalization Among Non-Hispanic Black Com…

Basem Mishriky

Heart Failure, the Picture is Changing: Q&A Discussion

Heart, Diabetes and Kidney: Make the Link

P. Seferovic, E. Standl, M. Ibrahim

Diabetes: Matters of the Heart

Scripps Health

M. Wilkinson

Updates in Preoperative Evaluation in Patients Undergoing Non-cardia…

37th Annual Advances in Heart Disease

R. Eshima Mckay

GLP1-RA and Risk of Stroke

Heart in Diabetes (HiD)

L. A. Leiter

How Spatial Metabolomics Revolutionizes Our Understanding of Diabeti…

UT Health San Antonio School of Medicine

K. Sharma

Genetics in Cardiovascular Disease

Scripps Health

E. Guarneri

Cross Talk Between Obesity, Fatty Liver and Metabolic Syndrome

Houston Methodist DeBakey Heart and Vascular Center

D. W. Victor III

Integrative Medicine and Global Health Priority

Scripps Health

E. Guarneri

Dual Pathway Inhibition in the Cardiometabolic Patient: How Effectiv…

Cardiometabolic Health Congress (CMHC)

D. Bhatt

Update in Diabetes and Cardiovascular Health

Emory Diabetes Education Training Academy

G. Umpierrez

What Are the Key Components of Primary CVD Prevention from ACC/AHA G…

Houston Methodist DeBakey Heart and Vascular Center

S. Virani

Cardiovascular Benefits Associated with Current Pharmacotherapies in…

KDIGO

E. Michos

Hypertension Awakenings: Finally Something New to Talk About

Heart in Diabetes (HiD)

R. R. Townsend

ESC 2023 Insights: 2023 ESC Guidelines for the Management of Cardiov…

ESC 2023 Insights

N. Marx